Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Planta Med. 2010 Aug 17;77(3):265–270. doi: 10.1055/s-0030-1250259

Figure 2.

Figure 2

Bioactivity-directed fractionation of cranberry, and inhibitory effects on intestinal CYP3A activity in vitro, as measured by midazolam 1′-hydroxylation. Circled fractions were carried forward in purification processes. Bars denote means of duplicate incubations using HIM as the enzyme source. Ketoconazole (1 μM) was used as a positive control for CYP3A inhibition and inhibited activity by >90%.